The facility is designed to meet all FDA, EMA and GMP requirements in its operational support systems, technology and resource management
MedPharm, a contract developer of topical and transdermal pharmaceutical products, is opening a location in Raleigh-Durham, North Carolina to expand its CDMO services.
Doubling the company’s existing footprint, the facility will support process development, clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products.
This site, located within a few miles of the company’s current centre for topical and transdermal development, gives clients the opportunity to manufacture clinical batches and commercial scale products in the US.
“MedPharm’s investment in this facility is a clear demonstration of our continued commitment to a global vision by expanding client services downstream into commercial manufacturing’ said Eugene Ciolfi, MedPharm’s President and CEO.
“MedPharm’s newest facility is an extension of our development services and will also support our client base with their clinical and commercial pipelines needs for topical and transdermal products globally.”
The facility is designed to meet all FDA, EMA and GMP requirements in its operational support systems, technology and resource management.